Abstract
Background: Nano-crystalline suspensions obtained by top down process are used to overcome the poor water solubility of Active Pharmaceutical Ingredient (API).
Discussion: Nano-crystalline suspensions are a versatile technology and can be used for administering drug via different application routes. They are manufactured mainly by using technologies like stirred bead milling and high pressure homogenization. To make nano-crystalline suspensions successful as drug delivery system, several aspects needs to be considered in terms of formulation composition, manufacturing process and the technology to be used for particles size reduction.
Conclusion: This paper reviews all above aspects though eyes of engineer and industrial production feasibility. In addition to that, this review outlines importance of technology selection to obtain the desired particle size and product in compliance to pharmaceutical regulation. Finally, the important parameters and factors are outlined for the industrial manufacturing process.
Keywords: Formulation, High Pressure Homogenization (HPH), industrial production, milling, modeling, nano-crystalline, nano-suspension, stabilization, surfactant.
Graphical Abstract
Drug Delivery Letters
Title:Nano-crystalline Suspensions by Top Down Processes: Review of Manufacturing Considerations
Volume: 8 Issue: 3
Author(s): Mostafa Nakach*, Ranjita Shegokar*, Jean-René Authelin and Tharwat Tadros
Affiliation:
- Sanofi R&D, 1, Impasse des ateliers 94403, Vitry sur Seine,France
- Freie Universitat Berlin, Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Kelchstr. 31, 12169 Berlin,Germany
Keywords: Formulation, High Pressure Homogenization (HPH), industrial production, milling, modeling, nano-crystalline, nano-suspension, stabilization, surfactant.
Abstract: Background: Nano-crystalline suspensions obtained by top down process are used to overcome the poor water solubility of Active Pharmaceutical Ingredient (API).
Discussion: Nano-crystalline suspensions are a versatile technology and can be used for administering drug via different application routes. They are manufactured mainly by using technologies like stirred bead milling and high pressure homogenization. To make nano-crystalline suspensions successful as drug delivery system, several aspects needs to be considered in terms of formulation composition, manufacturing process and the technology to be used for particles size reduction.
Conclusion: This paper reviews all above aspects though eyes of engineer and industrial production feasibility. In addition to that, this review outlines importance of technology selection to obtain the desired particle size and product in compliance to pharmaceutical regulation. Finally, the important parameters and factors are outlined for the industrial manufacturing process.
Export Options
About this article
Cite this article as:
Nakach Mostafa*, Shegokar Ranjita*, Authelin Jean-René and Tadros Tharwat, Nano-crystalline Suspensions by Top Down Processes: Review of Manufacturing Considerations, Drug Delivery Letters 2018; 8 (3) . https://dx.doi.org/10.2174/2210303108666180706144005
DOI https://dx.doi.org/10.2174/2210303108666180706144005 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers